Palisade Bio

PALI · NASDAQ

$1.43+$0.09 (+6.72%)TodayMarket closed ·
Prev close $1.34

Latest news

  • Press releaseGlobe Newswire

    Palisade Bio Presents Rapid Endoscopic Improvement and New Translational Evidence for PALI-2108 in Inflammatory Bowel Disease at UEG Week 2026

  • Press releaseGlobe Newswire

    Palisade Bio Presents New Clinical, Pharmacokinetic, Pharmacodynamic and Mechanistic Data Strengthening the Phase 2 Rationale for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at ACG 2026

  • Press releaseGlobe Newswire

    Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026

  • News

    Palisade Bio Receives Health Canada's Clearance For Its Clinical Trial Application For ASCENTRA-UC Trial Of PALI-2108 To Treat Severely Active Ulcerative Colitis

  • Press releaseGlobe Newswire

    Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance

  • Press releaseGlobe Newswire

    Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD

  • NewsAvi Kapoor

    ServiceTitan, Braze, Target Hospitality And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

  • Press releaseGlobe Newswire

    Palisade Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of PALI-2108 Into Phase 2 Development

  • Press releaseGlobe Newswire

    Palisade Bio to Participate in the Leerink Partners Therapeutics Forum

  • Press releaseGlobe Newswire

    Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis

  • Press releaseGlobe Newswire

    Palisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • NewsAvi Kapoor

    Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December

  • NewsAvi Kapoor

    Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session

  • NewsAvi Kapoor

    DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday

  • NewsAvi Kapoor

    Tilray Brands, SuperX AI Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • Press releasePRNewswire

    SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Palisade Bio, Inc. (NASDAQ: PALI)

  • NewsAvi Kapoor

    Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Why Alphabet Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • Press releaseGlobe Newswire

    Palisade Bio, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference

  • NewsVandana Singh

    What's Going On With Palisade Bio Stock On Thursday?

  • NewsAvi Kapoor

    Nasdaq Down 50 Points; US Initial Jobless Claims Rise

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.